跳至主要内容
临床试验/CTRI/2026/02/104636
CTRI/2026/02/104636尚未招募4 期

A randomized double arm comparative clinical study to evaluate the efficacy of Arjuna twak churna lepa and Panchavalkala churna lepa along with Patoladi kashaya in the management of Vyanga vis-a-vis Melasma

Dr Ranjini Kuruwatti1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年3月6日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50
试验地点
1

研究概览

简要总结

Skin disorders have a significant impact on physical appearance and psychological wellbeing  with melasma being one of the most common hyperpigmentation disorders affecting the face especially in women of reproductive age  In Ayurveda Vyanga is described under Kshudra Roga and closely resembles melasma in its clinical presentation It is characterized by painless thin dark patches over the face due to vitiation of Vata and Pitta Dosha with involvement of Rakta and Twak

Conventional treatments for melasma provide temporary improvement but are often associated with adverse effects recurrence and high cost creating a need for safe and effective alternative therapies  Ayurveda offers a comprehensive approach through Koshta Shodhana internal Shamana therapy and external Lepa application to correct Dosha imbalance and improve skin complexion

The present study is a randomized double arm comparative clinical trial designed to evaluate and compare the efficacy of Arjuna Twak Churna Lepa and Panchavalkala Churna Lepa administered along with Patoladi Kashaya in the management of Vyanga corresponding to melasma  A total of 50  patients will be included and treated for 30 days with follow up up to 60 days

Assessment will be carried out using subjective parameters such as itching and burning sensation and objective parameters including discoloration roughness number and size of lesions and MASI score  The study aims to establish the efficacy safety and comparative effectiveness of these Ayurvedic treatment modalities in managing melasma and to provide scientific evidence for their clinical utility

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Subjects presenting with the clinical features of Vyanga and Subjects with history of not more than one year of onset.

排除标准

  • Pregnant or lactating women Hyperpigmentation since birth History of other skin diseases like lupus eczema and psoriasis Subjects suffering from systemic disorders like HIV HBsAg positive Use of oral contraceptives hormone replacement therapy or steroids Allergy to any ingredients used in the intervention Active acne or other inflammatory facial disorders.

研究者

发起方
Dr Ranjini Kuruwatti
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Ranjini Kuruwatti

Ayurveda Seva Samitis Ayurveda Mahavidyalaya and Hospital Heggeri Extension Hubli

研究点 (1)

Loading locations...

相似试验